Peptidylprolyl isomerase A pseudogene 69 (PPIAP69)

Peptidylprolyl isomerase A pseudogene 69 (PPIAP69) is classified as a pseudogene in the human genome. Pseudogenes are DNA sequences similar to known genes but are generally non-functional due to mutations (such as premature stop codons, frame shifts, or lack of regulatory regions) and do not produce a functional protein product[5]. PPIAP69 is one among multiple pseudogenes related to the functional peptidylprolyl isomerase A (PPIA) gene, which encodes the cyclophilin A enzyme, but there is no evidence that PPIAP69 itself encodes an active enzyme or participates in any known biological processes or diseases[2][5]. Notes and limitations: - There is extensive evidence and characterization for PPIA, the parent gene[1][2][5], and some PPIA pseudogenes (e.g., PPIAP22) can regulate the expression of PPIA via non-coding RNA mechanisms in specific contexts such as cancer[7], but there is no such evidence for PPIAP69. - The naming and gene structure are typical for processed or unprocessed pseudogenes; they are not considered therapeutic targets and do not have associated drugs, biomarkers, or known safety concerns. - If your intent was to query about cyclophilin A or peptidylprolyl isomerase A (PPIA, the functional gene), please specify, as that entry would have substantive coverage as a therapeutic target in immunology, oncology, and infectious diseases[1][2][4][5]. Summary of issues: - PPIAP69 is not a therapeutic target. - It is a non-coding pseudogene with no described biological function, drug interaction, or disease relevance. - No known interacting drugs, associated mechanisms, or biomarkers. - The entry is technically correct as a pseudogene name but incorrect if intent was to find a functional protein or therapeutic target. If you need detailed information on the functional parent gene (PPIA, cyclophilin A) instead, please clarify.

Other names

PPIAP69